ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour...
ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
[...]line pembrolizumab monotherapy was started at progression based on the results of ctDNA sequencing (Guardant360 assay) showing RAS wild-type, a BRAF V600E mutation, and high microsatellite instability (MSI-h). Follow-up A durable response according to Response Evaluation Criteria in Solid Tumors version 1.1 to combination therapy with encorafe...
Alternative Titles
Full title
ICGC-ARGO precision medicine: an update on targeted therapy based on longitudinal analysis of tumour heterogeneity and evolution in colorectal cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2761976514
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2761976514
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(22)00650-7
